Evidence map›Paper›PMID 34080441›Full record

Trial reportAcupuncture in medicine : journal of the British Medical Acupuncture Society2021

Acupuncture for chronic pain in adults with sickle cell disease: a mixed-methods pilot study.

Hongjin Li, Crystal L Patil, Robert E Molokie, Franklin Njoku, Alana D Steffen, Ardith Z Doorenbos, Judith M Schlaeger

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Acupuncture in medicine : journal of the British Medical Acupuncture Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Chronic pain in the aging adult with sickle cell disease.Frontiers in pain research (Lausanne, Switzerland) · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Precision, integrative medicine for pain management in sickle cell disease.Frontiers in pain research (Lausanne, Switzerland) · 2023
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hongjin LiDepartment of Biobehavioral Nursing Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0002-5466-1192
Crystal L PatilDepartment of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, USA.
Robert E MolokieDepartment of Hematology/Oncology, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Franklin NjokuDepartment of Hematology/Oncology, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Alana D SteffenDepartment of Population Health Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, USA.ORCID 0000-0003-4292-6138
Ardith Z DoorenbosDepartment of Biobehavioral Nursing Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA.
Judith M SchlaegerDepartment of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, USA.
University of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · US

Funding

NIH Health Care Systems Research Collaboratory-Coordinating Center (U24)U24AT009676 · NCCIH · DUKE UNIVERSITY · PI LESLEY H CURTIS, Adrian Hernandez · 2017 to 2026
$21.5M
HEAL Collaboratory Resource Coordinating Center (PRISM) (U24): Bioethics SupplementU24AT010961 · NCCIH · DUKE UNIVERSITY · PI CURTIS, LESLEY H, HERNANDEZ, ADRIAN · 2019 to 2021
$6.4M
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease PainUH3AT011265 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOORENBOS, ARDITH Z, EZENWA, MIRIAM OMELEBELE · 2021 to 2024
$6.4M
A Stress and Pain Self-management m-Health App for Adult Outpatients with Sickle Cell DiseaseR01NR018848 · NINR · UNIVERSITY OF FLORIDA · PI EZENWA, MIRIAM OMELEBELE · 2020 to 2024
$2.9M
Applying Technology to Problems in Pain and Symptom ManagementK24NR015340 · NINR · UNIVERSITY OF WASHINGTON · PI DOORENBOS, ARDITH Z · 2014 to 2018
$842k
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease PainUG3AT011265 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOORENBOS, ARDITH Z, EZENWA, MIRIAM OMELEBELE · 2020 to 2020
$827k
Providing training in effective non-opioid options for the treatment of pain conditions.K24AT011995 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOORENBOS, ARDITH Z · 2021 to 2021
$324k
NCCIH NIH HHS K24 AT011995NCCIH NIH HHS U24 AT009676NCCIH NIH HHS U24 AT010961NCCIH NIH HHS UG3 AT011265NCCIH NIH HHS UH3 AT011265NINR NIH HHS K24 NR015340NINR NIH HHS R01 NR018848
6 · The paper itself

Abstract

objectiveChronic pain is a common symptom experienced among patients with sickle cell disease (SCD). Our aims were to assess the feasibility and acceptability of performing acupuncture for the treatment of chronic pain in adults with SCD.

methodsThis was a single-arm, prospective pilot study of six adults with SCD. Participants reported ⩾ 3 months of chronic pain and were > 18 years of age. Per protocol, acupuncture was to be administered twice per week for 5 weeks, for 30 min per session. All treatments were performed in the acupuncture treatment laboratory at the University of Illinois Chicago College of Nursing. Pain intensity, pain interference, and other symptoms were measured at baseline and after the intervention. Participants completed a semi-structured interview and a protocol acceptability questionnaire after the acupuncture intervention.

resultsSix participants (mean age 52.5 years, six Black) were enrolled. Although the study was suspended due to COVID-19 and not all participants completed the 10-session protocol, completion rates were high with no missed appointments. One participant did not complete the study due to hospitalization unrelated to acupuncture. No adverse events were reported. At completion of the intervention at 4-5 weeks post-baseline, all participants had reduced pain intensity and pain interference. The mean acceptability score on the protocol acceptability questionnaire was 82%.

conclusionIt was feasible and acceptable to implement acupuncture in adults with SCD. This study can be used to guide a larger randomized controlled trial to evaluate the effect of acupuncture on reducing chronic pain in adults with SCD.

Indexed as

Acupuncture TherapyAdultAnemia, Sickle CellChronic PainFeasibility StudiesFemaleHumansMaleMiddle AgedPain ManagementPain MeasurementPatient Acceptance of Health CarePilot ProjectsProspective StudiesTreatment Outcomeacupuncturepainsickle cell disease

Identifiers

PMID34080441
PMCPMC8530874
OpenAlexW3165189571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.